HIV-1 DNA vaccines
- 28 January 1999
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 65 (1-2) , 127-131
- https://doi.org/10.1016/s0165-2478(98)00135-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A vaccine for HIV type 1: The antibody perspectiveProceedings of the National Academy of Sciences, 1997
- ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.Journal of Clinical Investigation, 1995
- Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1995
- HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian womenNature Medicine, 1995
- Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for TherapyScience, 1993
- HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infantThe Lancet, 1993
- Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibodyNature, 1992
- Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeysNature, 1991
- HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptidesNature, 1988
- Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.Proceedings of the National Academy of Sciences, 1988